Skip to main content

Find Clinical Trials

Home
Conditions
Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas

Clinical trial condition

Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas

Explore clinical trials studying Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas trial results

Completed

Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas

NCT02030834

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details